Skip to main content

Wellthy Acquires Cleo as Two Leaders Come Together to Create the Singular Platform for Family Care

Wellthy’s acquisition of Cleo brings together two leaders in family care, expanding support for employers, health plans, and families. NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) — Wellthy today announced its acquisition of Cleo, bringing together two leaders in family care around a shared vision: creating the singular platform for family care. Together, Wellthy and Cleo will combine deep human expertise, intelligent technology, and complementary capabilities to help employers, health plans, and families across the full continuum of need—from the everyday moments of growing and caring for a family to some of life’s most complex health and caregiving challenges around the globe. Family care rarely follows a straight line. Needs evolve, overlap, and often span generations at once. A new parent may also be caring for an aging parent....

Continue reading

Schouw & Co. share buy-back programme, week 37 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 4 September 2026 370,083 680.43 251,814,550    Monday,...

Continue reading

Stewards Provides Update on Proposed PIXL and Envy Acquisitions

Previously disclosed non-binding LOIs contemplate approximately $240 million in aggregate implied property value across two South Florida multifamily properties totaling approximately 544 units FORT LAUDERDALE, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — Stewards, Inc. (Nasdaq: SWRD) (“Stewards” or the “Company”), a diversified financial platform spanning private credit, real assets and technology, today provided an update regarding its previously disclosed non-binding letters of intent (“LOIs”) for the proposed acquisitions of PIXL at Plantation and Envy Pompano Beach, two South Florida multifamily properties comprising approximately 330 and 214 units, respectively. The Company previously disclosed the LOIs in its Quarterly Report on Form 10-Q for the quarter ending June 30, 2026. Under the terms contemplated by the LOI, Stewards would...

Continue reading

Form-8.3 APTITUDE SOFTWARE GROUP PLC – 11 09 2026 – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree APTITUDE SOFTWARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: APTITUDE...

Continue reading

Update on Scheme of Arrangement

TORONTO and PERTH, Western Australia, Sept. 14, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) refers to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (“CAML”) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (“Scheme”). Capitalised terms in this announcement that are not otherwise defined have the meanings given to them in the Scheme Booklet dated 13 August 2026 (“Scheme Booklet”). Scheme Meeting reminder As outlined in the Scheme Booklet, the Cygnus shareholder meeting to approve the Scheme (“Scheme Meeting”) is scheduled to take place at the offices of Hamilton Locke at Level 39, 152-158 St Georges Terrace, Perth WA 6000 at 2.00pm (AWST) on 18 September 2026....

Continue reading

Capgemini signs a definitive agreement to sell Capgemini Government Solutions

Media RelationsSam ConnattyTel.: +44 (0) 7811 486517E-Mail: sam.connatty@capgemini.com Investor Relations:Vincent BiraudTel.: +33 1 47 54 50 87E-mail: vincent.biraud@capgemini.com Capgemini signs a definitive agreement to sell Capgemini Government Solutions Paris, September 12, 2026 – Capgemini today announces that it has entered into an agreement with ITC Federal, a US IT solutions and enterprise services provider to federal law enforcement, homeland security and defense agencies, for the sale of Capgemini Government Solutions, its subsidiary working with the US federal government. This transaction is expected to close in the coming weeks, subject to customary conditions for a transaction of this nature. As indicated when the Group announced the launch of the divestment process earlier this year, Capgemini Government Solutions represented...

Continue reading

Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)

HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (the “Company”) today announced that the Company’s Board of Directors has approved a 1 for 12.62 reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock“). The reverse stock split will become effective at 12:01 a.m., Eastern Time, on September 23, 2026. Starting with the opening of trading on that date, the Company’s Common Stock will continue to trade on the NYSE American Exchange under the ticker symbol “IBO” and will trade under a new CUSIP number to be assigned in connection with the reverse stock split. On December 30, 2025, the Company’s stockholders approved a second reverse stock split of the Company’s Common Stock at a ratio of not less than 1-for-12.48 and...

Continue reading

National Advertising Division Recommends Nucleus Genomics Modify or Discontinue Certain Claims for Nucleus IVF+ Embryo Screening; Nucleus to Appeal

In a monitoring inquiry, BBB National Programs’ National Advertising Division recommended that Nucleus Genomics, Inc. modify or discontinue certain express and implied advertising claims for its Nucleus IVF+ service, including claims that Nucleus IVF+ could accurately compare embryos’ disease risks, identify which embryo would grow up tallest or smartest, and determine a future child’s eye and hair colors. Nucleus will appeal the National Advertising Division’s (NAD) decision New York, NY, Sept. 11, 2026 (GLOBE NEWSWIRE) — In a monitoring inquiry, BBB National Programs’ National Advertising Division recommended that Nucleus Genomics, Inc. modify or discontinue certain express and implied advertising claims for its Nucleus IVF+ service, including claims that Nucleus IVF+ could accurately compare embryos’ disease risks,...

Continue reading

Futuremain Co., Ltd. enters into definitive business combination agreement with ChampionsGate Acquisition Corp

SUWON-SI, REPUBLIC OF KOREA and MONTEREY, CA, Sept. 11, 2026 (GLOBE NEWSWIRE) — Futuremain Co., Ltd. (“Futuremain”), a global engineering and IT company specializing in safety diagnostics of machinery operating in factories, has entered into an Agreement and Plan of Merger and Business Combination Agreement (the “BCA”) with ChampionsGate Acquisition Corp (“ChampionsGate”), a publicly traded special purpose acquisition company, as well as such other persons who are contemplated to later join this Agreement as the “Pubco”, “Holdco”, “Merger Sub I” and “Merger Sub II”. Upon completion, the transaction contemplated under the BCA will result in a combined company listed on the Nasdaq Stock Market. The transaction is expected to close in 2027, subject to regulatory approvals,...

Continue reading

Hypercharge Enters into Letter of Intent to Acquire REVS Charging LLC

VANCOUVER, British Columbia, Sept. 11, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading EV charging operator, is pleased to announce that it has entered into a non-binding letter of intent, dated May 27, 2026, with REVS Charging LLC (“REVS”), a Texas-based provider of electric vehicle charging solutions, pursuant to which Hypercharge is proposing to acquire 100% of the equity interests in REVS (the “Proposed Transaction”). The Proposed Transaction, if completed, would establish Hypercharge’s first US-based operating platform and accelerate the Company’s strategy of consolidating attractively valued EV charging businesses with recurring revenue, long-term contracted customers and meaningful opportunities for operating synergies as the Company scales its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.